David Hellerstein on COMPASS’s Phase IIb trial: Psilocybin Therapy for TRD

Published 2022-03-02

Recommendations

Similar videos

02:31

George Goldsmith on COMPASS’s Phase IIb Trial: Psilocybin Therapy for Treatment-Resistant Depression
02:34

Dr Stephanie Knatz Peck on Treatment-Resistant Depression and COMPASS Pathways’ Phase IIb Trial
11:12

We NEED to Talk about the Compass Pathways Psilocybin-for-Depression Trial Results: A WIN for CMPS??
02:12

COMP360 psilocybin reduces depression symptoms: Phase 2b trial findings
03:09

COMPASS Pathways to fund study of COMP360 psilocybin in autistic adults
00:55

George Goldsmith: Thank you to everyone involved in COMPASS’s Phase IIb Trial
1:38:53

Therapeutic Use of Psychedelic and Dissociative Medications in Psychiatry
09:52

How Psilocybin works: why it helps serious depression?
23:20

4 NEW Psychedelics Trial Updates in 1 Day | Psilocybin, LSD, 18MC + Microdosing [MNMD, CMPS, FH]
26:43

Take a Trip: The Promise and Pitfalls of Psychedelic Healthcare
More results